Novel Use of Doxycycline in Continuous-Instillation Negative Pressure Wound Therapy as “Wound Chemotherapy”

Foot & Ankle Specialist

Volumn 3, Issue 4, 2010, Pages 190-193

  Scimeca, Christy L ^a   Bharara, Manish ^a   Fisher, Timothy K ^a   Giovinco, Nicholas ^a   Armstrong, David G ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

amputation and limb salvage; inflammation; nonhealing ulcer

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ARTICLE; CASE REPORT; DRUG INSTILLATION; FEMALE; HUMAN; METHODOLOGY; ORAL DRUG ADMINISTRATION; SKIN ULCER; VACUUM ASSISTED CLOSURE;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; FEMALE; HUMANS; INSTILLATION, DRUG; NEGATIVE-PRESSURE WOUND THERAPY; SKIN ULCER;

EID: 78349274566     PISSN: 19386400     EISSN: None     Source Type: Journal    
DOI: 10.1177/1938640010371121     Document Type: Article

References (13)

1. Falanga V. Growth factors and chronic wounds: the need to understand the microenvironment. J Dermatol. 1992; 19: 667-672.
2. Wolvos T. Wound instillation-the next step in negative pressure wound therapy: lessons learned from initial experiences. Ostomy Wound Manage. 2004; 50: 56-66.
3. Baxter CR Immunologic reactions in chronic wounds. Am J Surg. 1994; 167: 12S-14S.
4. Giovinco N. Wound chemotherapy by the use of negative pressure wound therapy and infusion. Eplasty. 2009; 10(e9).
5. Armstrong D., Jude D. The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc. 2002; 92: 12-18.
6. Lobmann R., Ambrosch A., Pittasch D., Waldmann K., Schieweck S., Lehnert H. Expression of MMP-8 and TIMP-2 in diabetic and non-diabetic wounds [abstract]. Diabetologica. 2000; 43(suppl 1):A15.
7. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck A., Lehnert H. Expression of gelatinase (MMP-2) in diabetic and non-diabetic wounds [abstract]. Diabetologica. 2001; 44(suppl 1):A4.
8. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck S., Lehnert H. Expression of matrix metalloproteinases and their inhibitors in wounds of diabetic and non-diabetic patients. Diabetologica. 2002; 45: 1011-1016.
9. Lobmann R., Schultz G., Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care. 2005; 28: 461-471.
10. Chin GA, Thigpin TG, Perrin KJ, Moldawer LL, Schultz GS Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, doxycycline. Wounds. 2003; 15: 315-323.
11. Lamperter S., Slight S., Weber K. Doxycycline and tissue repair in rats. J Lab Clin Med. 2002; 139: 295-302.
12. Armstrong DG, Lavery LA Negative pressure wound after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005; 366: 1704-1710.
13. Stechmiller J., Cowan L., Schultz G. The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds. Biol Res Nurs. 2009; 11: 336-344.